Wutah dodolan YoY sajrone 12 wulan kepungkur: Xencor, Inc. (XNCR)

Logo perusahaan publik Xencor Inc. (XNCR)

Geopolitical risks are complicating international trials and material supplies for Xencor, Inc. (XNCR). However, patent protection for molecules and licenses create a formidable barrier for competitors, while the XmAb platform accelerates the launch of new drugs. The year-over-year (12-month) relative revenue growth rate demonstrates the current resilience of the business model, with the indicator standing at 33.30, which defines the company's current development trend.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Xencor (XNCR): kanggo periode 11.02.2024 - 18.11.2026

Xencor (XNCR) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:Xencor, Inc.
Sampel barang xencor.com

Efficient resource allocation toward R&D and the successful licensing of Xencor, Inc. (XNCR) technologies establish a foundation for a stable capital inflow. By analyzing the year-over-year dynamics of commercial revenues on a rolling basis, investors can assess the daily revenue growth rate over 12 months compared to the same period last year, enabling a real-time assessment of actual demand for the issuer's products and the mitigation of risks associated with decelerating growth.

Pesaing Xencor, Inc. (XNCR)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur CMPX|Wutah dodolan YoY (TTM) REPL (Replimune)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur LYEL|innate-pharma.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Pyxis Oncology|Compugen Limited (CGEN) - Wutah dodolan YoY sajrone rolas wulan kepungkur|IO Biotech, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|STRO (sutrobio.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) MiNK Therapeutics Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur werewolftx.com (HOWL)|IMMX: Wutah dodolan taun lumaku|alxoncology.com - Wutah pendapatan YoY sajrone 12 wulan kepungkur|CUE - Wutah pendapatan YoY sajrone 12 wulan kepungkur|PDSB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur Sonnet BioTherapeutics Holdings SONN|MAIA: Wutah dodolan YoY (TTM)|LIMN - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur LVTX|Wutah dodolan YoY sajrone 12 wulan kepungkur NXTC (NextCure)|Wutah dodolan YoY sajrone rolas wulan kepungkur leaptx.com (LPTX)|INTS - Wutah pendapatan taun lumaku|Wutah dodolan YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Theriva Biologics, Inc. (TOVX)|GRTS: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur kinetabio.com KA|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur